|
Age, years
|
< 0.001
|
|
18–25
|
50 (17.9)
|
22 (36.7)
| |
|
26–35
|
134 (48.0)
|
31 (51.7)
| |
|
36–45
|
66 (23.7)
|
6 (10.0)
| |
|
> 45
|
29 (10.4)
|
1 (1.7)
| |
|
Sex
|
0.003
|
|
Males
|
101 (36.2)
|
10 (16.7)
| |
|
Females
|
178 (63.8)
|
50 (83.3)
| |
|
WHO Stage
|
0.78
|
|
I
|
84 (30.1)
|
15 (25.0)
| |
|
II
|
82 (29.4)
|
19 (31.7)
| |
|
III
|
89 (31.9)
|
22 (36.7)
| |
|
IV
|
24 (8.6)
|
4 (6.7)
| |
|
Weight, kg
|
49.2 (44.1; 54.3)
|
47.3 (42.1; 51.3)
|
0.08
|
|
Fat Free mass, Kg
|
39.0 (35.2; 44.8)
|
37.1 (33.7; 40.1)
|
0.01
|
|
Fat mass, kg
|
8.4 (6.0; 11.9)
|
9.9 (7.2; 11.6)
|
0.49
|
|
Height, m
|
1.60 (1.54; 1.67)
|
1.6 (1.5; 1.6)
|
0.02
|
|
Body mass index, kg/m2
|
18.9 (17.4; 20.6)
|
18.3 (17.2; 20.5)
|
0.78
|
|
On tuberculosis treatment, Yes
|
30 (10.8)
|
5 (8.3)
|
0.58
|
|
C-reactive protein, mg/L
|
2.0 (0.6, 7.7)
|
1.9 (0.4; 6.8)
|
0.57
|
|
CD4 count, cells/ul
|
178 (111; 243)
|
192 (122; 231)
|
0.45
|
|
Serum phosphate, mmol/La
|
1.3 (0.3))
|
1.3 (0.3))
|
0.89
|
|
Hepatitis B surface antigen positive2, Yes
|
10 (3.7)
|
2 (3.6)
|
0.97
|
|
Viral load, log (copies+ 1/mL)
|
4.8 (4.3; 5.4)
|
4.8 (4.3; 5.2)
|
0.79
|
|
Urine Protein dipstick positive3, Yes
|
14 (2.3)
|
1 (6.6)
|
0.28
|
|
eGFR, ml/min/1.73m2 a
|
117.7 (21.7)
|
122 (18.0)
|
0.13
|
